RSV Vaccinations

RSV is one of the common viruses that cause coughs and colds in winter. RSV is transmitted by large droplets and by secretions from contact with an infected person. Symptons can include:
• Cough
• Sore throat
• Sneezing
• Runny or blocked nose

From 1 September 2024, 2 new respiratory syncytial virus (RSV) vaccination programmes will be introduced, those eligible will be invited in the upcoming weeks. Please note this vaccine must be given separately to your Flu & COVID vaccine.

Programme for older adults aged 75 to 79 years old

All adults turning 75 years old on or after 1 September 2024 will be eligible for the routine programme and should be offered a single dose of the RSV vaccine. A one-off catch-up campaign for those already aged 75 to 79 years old on 1 September 2024 will be undertaken at the earliest opportunity.

Programme for pregnant women to protect infants

All women who are at least 28 weeks pregnant (the eligible cohort) on 1 September 2024, will be offered a single dose of the RSV vaccine. After that, pregnant women will become eligible as they reach 28 weeks gestation and remain eligible up to birth

In some cases, RSV can cause wheezing, shortness of breath, pneumonia, and other serious conditions. While most infections resolve on their own, RSV can be particularly severe in individuals with heart or lung disease or weakened immune systems. Each year, thousands of older adults require hospitalisation due to RSV.

Protect your health with the RSV vaccine – schedule your appointment today! Click Here for more information from the .gov website